Clinical Trial Update: Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period

View source ↗

Summary

This completed study evaluates the effectiveness of daclatasvir-based regimens for chronic hepatitis C in Europe, using data from a named-patient program and ea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daklinza (Daclatasvir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Status: COMPLETED